Product description Brand name COMIRNATY that has been approved recently by Health Canada Company name BioNTech Manufacturing GmbH Ingredient mRNA encoding SARS-CoV-2 spike protein, 5’ [m27,3’-OGppp(m12’-O)ApG] cap, 110-nucleotide 3′ poly(A) tail with a 10-nucleotide linker sequence. This product (COMIRNATY) includes an update to the antigen composition (variant Omicron KP.2) and replaces COMIRNATY Omicron XBB.1.5 (raxtozinameran).
Ottawa – Several vaccines for COVID-19 are authorized and available for use in Canada. These include messenger ribonucleic acid (mRNA) vaccines (preferred) and a protein subunit vaccine. The XBB.1.5 vaccines are now the recommended products. Refer to Preparations authorized for use in Canada for more information. Novel coronavirus disease 2019 (COVID-19) is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). …
NEW YORK — Pfizer Inc. (NYSE: PFE, “Pfizer”) and BioNTech SE (Nasdaq: BNTX, “BioNTech”) announced top-line results from their Phase 3 clinical trial to evaluate the companies’ combined mRNA vaccine candidate against influenza and COVID-19 in healthy individuals 18-64 years of age. The Phase 3 randomized, observer-blinded study (NCT06178991) enrolled more than 8,000 adults 18 through 64 years of age to evaluate the …
Ottawa – Every person in Canada deserves to age with dignity, safety, and comfort, regardless of where they live. While many Canadians want to age in their own home, they also expect and deserve that high quality long-term care options are available. That is why the Government of Canada is developing a Safe Long-Term Care Act. Health Canada released the …
Ottawa – As of June 2023, the majority of Canadians had been infected by the virus causing COVID-19. Most people recover from their symptoms and are able to carry on with their lives, however, for many others, symptoms persist for months, often impacting their ability to work and their quality of life overall. A new study released today, “Experiences of Canadians …
Toronto – Toronto Public Health (TPH) presented ongoing vaccination rate challenges among school-aged children to the Board of Health, a concern intensified by pandemic-related disruptions. The board adopted the recommendation that Toronto’s Medical Officer of Health, Dr. Eileen de Villa, seek $3.8 million from the Ministry of Health to address gaps identified in a recent Public Health Ontario report. The …
Toronto – Mayor Olivia Chow proclaimed November 10 as Immunization Day in Toronto. Every year on November 10, World Immunization Day is dedicated to highlighting the effectiveness of vaccines and promoting their use to safeguard against vaccine-preventable diseases. This day underscores the pivotal role of immunization in protecting the health of individuals and communities. The Mayor’s Immunization Day proclamation is …
Current recommendations An updated Covid-19 vaccine has been approved by Health Canada and will be available for use. Covid-19 vaccination reduces the risk of severe illness, death and post Covid-19 condition (long Covid). Starting in fall 2023, it’s recommended that you get an updated Covid-19 vaccine dose if it’s been at least 6 months: since your last Covid-19 vaccine dose …
Washington – Scientists at the US Centres for Disease Control and Prevention (CDC) are warning of a new, highly mutated lineage of the virus that causes COVID-19, calling it a deadlier version of the virus. The CDC identified the new lineage by the name BA.2.86 on the messaging platform X, saying: “As we learn more about BA.2.86, CDC’s advice on …
NEW YORK— Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced they have reached an agreement with the European Commission (EC) to amend their existing contract to deliver Covid-19 vaccines to the European Union. The amended agreement reflects the companies’ commitment to working collaboratively to help address ongoing public health needs, while respecting the principles of the original …
